Appointments of CSO and Head of R&D

AI SummaryClose X

ImmuPharma PLC announced the promotions of Dr. Sébastien Goudreau to Chief Scientific Officer and Dr. Laura Mauran-Ambrosino to Head of Research and Development. These appointments coincide with the filing of a new patent application for their lead asset, P140. The company believes this new patent on P140 is a major step forward. The company is moving forward with partnering and commercializing its product portfolio, particularly P140.

Disclaimer*

Companies

Immupharma (IMM)
UK 100

Latest directors dealings